BRCA2 and neoplasm: For the tumor with a somatic BRCA2 mutation with LOH (M096), which was not identified as HRD by the BRCA1/2-like classifier and CHORD, the normal control was shown to contain significant contamination with tumor DNA, which is likely to have compromised the somatic mutation calling.